Health

  • October 21, 2026

    7 Firms Advise EQT, Qiagen On $12.1B Take-Private Deal

    A long list of firms — including Davis Polk & Wardwell LLP, Linklaters LLP and Milbank LLP — are steering Sweden-based EQT Private Equity's $12.1 billion takeover of life sciences testing company Qiagen NV, according to a Wednesday announcement.

  • October 21, 2026

    Reckitt Benckiser Denies Firing Manager For Whistleblowing

    Reckitt Benckiser urged a New Jersey federal judge to end a former senior regulatory manager's suit alleging she was fired for raising product safety issues, arguing Tuesday she rejected a lateral transfer amid a global reorganization and unsuccessfully gambled the company would give in to her promotion and higher pay demands.

  • October 21, 2026

    Ill. Judge Questions Bid To Block 340B Drug Discount Law

    An Illinois federal judge seemed hesitant Wednesday to halt a state law barring drugmakers from trying to impose restrictions on pharmacies under contract with a federal drug pricing discount program, saying the state seems to be maximizing public health in an area the statute doesn't address.

  • October 21, 2026

    9th Circ. Judges Hint Hospital CBA May Mandate Arbitration

    A Ninth Circuit panel appeared receptive on Wednesday to Long Beach Memorial Medical Center's argument that a nurse should be forced to individually arbitrate proposed class break claims, with two judges suggesting that a union contract's repeated references to Golden State labor law bolster the hospital's position.

  • October 21, 2026

    PBM Fee Disclosure Rule Clears White House Review

    A White House budget office has completed review of a rule from the U.S. Department of Labor's employee benefits arm that would require new fee disclosures from pharmacy benefit managers, which act as intermediaries between drugmakers, pharmacies and insurers.

  • October 21, 2026

    4 Firms Steer Cencora's $2.4B American Oncology Acquisition

    Pharmaceutical distribution company Cencora unveiled plans Wednesday to acquire American Oncology Network Inc. in a deal that values the network at an enterprise value of $2.4 billion and was built by four law firms.

  • October 21, 2026

    Linde Seeks $1.2M Clawback From Exec Who Joined Rival

    International industrial and healthcare gas supplier Linde PLC is seeking to recover more than $1.2 million in stock and performance rewards gains from Joseph H. Porto III, the onetime executive director of growth at Linde Gases U.S., after Porto allegedly left for a competitor.

  • October 21, 2026

    Intuitive Surgical Strikes $450M Deal In Robot Antitrust Suit

    Intuitive Surgical said in its quarterly earnings report Tuesday that it reached a $450 million settlement to resolve a hospital class action alleging it monopolized the market for servicing its da Vinci surgical robots, subject to approval by a California federal judge.

  • October 21, 2026

    Amarin Ends 'Skinny Label' Patent Case Against Hikma

    Amarin Pharma Inc. is dropping its patent suit over Hikma Pharmaceuticals USA Inc.'s generic version of a heart drug that uses a so-called skinny label, months after the U.S. Supreme Court shut the case down.

  • October 21, 2026

    Squire Patton Lands Akerman's Public Finance Co-Leader

    Squire Patton Boggs LLP announced Wednesday that it has added the co-chair of Akerman LLP's public finance group to bolster its capacity to handle public finance, healthcare finance and other matters.

  • October 21, 2026

    Pa. Panel Sets 3-Year Limit On Minimum Wage Claims

    A split Pennsylvania appeals court panel ruled Wednesday that workers have three years, not six, to sue for unpaid wages under the state's minimum wage law, siding with a pharmacy accused of shorting 20 employees on overtime pay.

  • October 21, 2026

    Wachtell Lipton Guides Abbott Nutrition Spinoff

    Wachtell Lipton Rosen & Katz guided healthcare company Abbott in a plan to spin off its nutrition business into an independent, publicly traded company anchored by brands such as adult supplement Ensure and infant formula Similac.

  • October 21, 2026

    SEIU Fired Organizer Over Military Leave, Suit Says

    An SEIU organizer was subjected to intense scrutiny and ultimately fired for taking time off to fulfill her obligations as a member of the U.S. Army Reserve, according to a new lawsuit filed in Pennsylvania federal court.

  • October 21, 2026

    High Court Lets Block On Prison Gender Care Ban Stand

    The U.S. Supreme Court on Wednesday allowed federal prisons to continue to offer gender transition medical services to incarcerated people.

  • October 20, 2026

    Feds Offer Up-Front Payments For Fraud Whistleblower Tips

    The U.S. Department of Justice on Tuesday announced the creation of a whistleblower incentive program offering up-front monetary awards for tips that lead to criminal fraud charges.

  • October 20, 2026

    Metabase, Pediatric Telehealth Biz Sued Over Patient Info Leak

    Open-source AI analytics company Metabase Inc. and pediatric telehealth provider Blueberry Medical failed to protect patients' personal health information from being exposed during a cybersecurity attack, and waited several weeks to notify affected individuals, alleges a proposed negligence class action filed Monday in California federal court. 

  • October 20, 2026

    Medical Device Co. Beats Investors' Alleged Demand Drop Suit

    A New York federal judge has dismissed a proposed shareholder class action alleging medical device maker Integer Holdings Corp. hid plummeting demand for cardiac devices and misled investors about its overall growth, concluding that the allegations do not suggest its disclosures in 2024 and 2025 were untrue or deceptive.

  • October 20, 2026

    Meta To Rereview MDL Privilege Claims Under Special Master

    Meta Platforms Inc. has agreed to have an independent special master rereview potentially thousands of documents the company withheld as privileged in social media addiction multidistrict litigation, after a California federal judge criticized Meta's privilege claims and refused to let Meta use an AI tool to rereview 170,000 documents at issue.

  • October 20, 2026

    Medtronic Sued Over Insulin Pump Failures

    Two women with diabetes on Monday accused Medtronic of knowingly selling insulin pumps with a known defect that can deliver the wrong amount of insulin that were recalled by the U.S. Food and Drug Administration in 2020.

  • October 20, 2026

    11th Circ. Rejects Ex-3M Worker's COVID Vax Refusal Suit

    The Eleventh Circuit on Tuesday declined to revive a Title VII religious discrimination suit by a former 3M healthcare business division employee who was terminated after refusing to get vaccinated against COVID-19 because of her beliefs, finding that her own statements show that there's no conflict between her beliefs and 3M's policy. 

  • October 20, 2026

    Mich. Pharmacist Tells 6th Circ. Feds Silenced Key Witness

    A Michigan pharmacist serving an eight-year prison sentence for medical fraud is entitled to a new trial, his attorney told a Sixth Circuit panel Tuesday, arguing that a key defense witness in the case was threatened by the government and dissuaded from testifying.

  • October 20, 2026

    2nd Circ. Won't Block Connecticut Drug Price Cap

    A Second Circuit panel affirmed a lower court's decision Tuesday, refusing to block Connecticut from enforcing a cap on generic and off-patent drug prices while a trade association for drug wholesalers challenges the statute.

  • October 20, 2026

    Comcast Says Workers Can Avoid Tobacco Surcharge  

    Comcast has asked a Pennsylvania federal judge to dismiss a proposed class action accusing it of violating federal benefits law by imposing a surcharge for tobacco use, saying its health and welfare benefit plan is "more generous" than required.

  • October 20, 2026

    REIT Says Narcan Dispenser Spiked Crime Near Apartments

    A real estate investment trust sued a Boston suburb Tuesday, blaming drug activity near its 146-unit apartment building on a public health initiative to provide a vending machine nearby for the overdose treatment Narcan. 

  • October 20, 2026

    7th Circ. Rejects Removal Of Hospital Patient Privacy Suits

    The Seventh Circuit on Tuesday joined a host of other appellate courts in determining healthcare providers were not "acting under" the federal government when they created patient web portals, finding actions alleging hospitals improperly shared patient information belonged in state court.

Expert Analysis

  • Insurer Spoliation Ruling Flags Continuing Duty To Preserve

    Author Photo

    An Illinois federal court’s recent decision to impose spoliation sanctions on the insurer in H.D. Smith v. Cincinnati Insurance provides practical guidance for navigating long-tail coverage litigation, underscoring the importance of evaluating preservation obligations in light of the full life cycle of a dispute, say attorneys at Morgan Lewis.

  • What DOJ Fraud Division Rule Resolves, And What It Doesn't

    Author Photo

    The U.S. Department of Justice’s recently published final rule answers many outstanding questions about the newly created National Fraud Enforcement Division, but overlapping mandates could result in parallel investigations and diverging viewpoints between multiple sets of prosecutors, say attorneys at Gibson Dunn.

  • Series

    Taekwondo Makes Me A Better Lawyer

    Author Photo

    Taekwondo has taught me to recognize when to fight for a position and when to focus on finding a solution, and that the best outcomes are often achieved by solving problems — all of which has improved my work as a bankruptcy lawyer, mediator and Subchapter V trustee, says Amy Denton Mayer at Berger Singerman.

  • Youth Center Investigation Shows Rising Governance Scrutiny

    Author Photo

    A recent New Hampshire attorney general report following its investigation into the state's Sununu Youth Services Center shows how organizations serving vulnerable populations can face scrutiny of their governance, safety practices and preparedness, even when investigators find no abuse, say attorneys at Morgan Lewis.

  • Target's ERISA Win Doesn't Ax Tobacco Surcharge Questions

    Author Photo

    Though a Minnesota federal court's recent dismissal of a putative class action challenging Target's tobacco surcharge wellness program offers employers a defense road map, courts' differing conclusions about the Employee Retirement Income Security Act versus U.S. Department of Labor requirements leave the legal landscape unsettled, say attorneys at McGuireWoods.

  • How 'Most Favored Nation' Regime Affects Biopharma Deals

    Author Photo

    As M&A activity surges in the biopharma space, companies will need to account for the Trump administration's most-favored-nation pricing proposals — durable in concept, if unsettled in detail — when drafting deals, say attorneys at Gibson Dunn.

  • Where DOJ's Fraud Priorities Memo May Actually Matter

    Author Photo

    The U.S. Department of Justice’s recently released memo outlining priorities for its newly created fraud division will shape how cases are identified, staffed and sequenced, meaning white collar defense work must begin earlier, say David Tarras at Tarras Defense and Trevor Jones at Dynamis.

  • What To Know As Legal Duty To Consider AI Takes Shape

    Author Photo

    While the U.K. Jurisdiction Taskforce’s recent statement on liability for artificial intelligence harms is nonbinding for both U.K. and U.S. lawyers, it highlights the importance of being able to distinguish between the availability of a tool and a professional obligation to use it, say Jonny Frank and Michael Costa at StoneTurn.

  • NC Dental Review Change Counters Tougher National Trend

    Author Photo

    North Carolina’s elimination of its prior review requirement for dental management agreements departs sharply from the national trend toward expanded corporate practice of medicine oversight, but stakeholders should not view this regulatory shift as a relaxation of compliance expectations, say attorneys at Holland & Knight.

  • DOJ Healthcare Declination Offers Self-Disclosure Checklist

    Author Photo

    The U.S. Department of Justice's declination of criminal charges against Campus Eye Management signals that its new self-disclosure policy provides a real path for healthcare companies to avoid criminal exposure, but that path is paved with speed, transparency and operational remediation, says Jonathan Porter at Husch Blackwell.

  • Series

    Being In A Band Made Me A Better Lawyer

    Author Photo

    Playing shows in storied New York City venues and rehearsing with my bandmates in poorly ventilated rooms helped develop the professional qualities I rely on as a litigator, including an ability to collaborate with strong-minded equals and the determination to treat each client with singular focus, says Eliad Shapiro at Herrick Feinstein.

  • Opinion

    Correctional Healthcare Requires Clearer Legal Standards

    Author Photo

    As the correctional healthcare industry increasingly faces financial instability due to litigation, the U.S. Bureau of Prisons should develop clear standards for constitutionally adequate care for incarcerated patients, says Susanne Moore at Blackstone Trial Group.

  • Mich. Ruling Gives Consumer Protection Law Its Teeth Back

    Author Photo

    The Michigan Supreme Court's recent decision in Attorney General v. Eli Lilly, overruling key holdings in two earlier cases, means that Michigan businesses can no longer defeat allegations of deceptive conduct under the state's consumer protection law simply by pointing to any governmental regulation of the business, say attorneys at DiCello Levitt.

  • Series

    Law School's Missed Lessons: Surviving A Long Trial

    Author Photo

    Most of law school trial advocacy is geared toward the sprint of trying a short case, but beyond managing a cross-examination or closing argument, effectively handling the marathon of a lengthy trial requires the ability to maintain composure, organization and credibility with the jury, says Mihir Elchuri at Hirschler.

  • AI Chatbot's Medical Claims Highlight Enforcement Risks

    Author Photo

    The Pennsylvania State Board of Medicine's recent lawsuit against Character Technologies, arguing that an artificial intelligence chatbot engaged in the unlicensed practice of medicine, may provide other state licensing boards with a road map for going after AI platforms, and counsel should advise clients to calibrate compliance accordingly, say attorneys at Cooley.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.